TNF and inflammatory bowel disease: Over the past 20 years, tumor necrosis factor (TNF)-antagonists have transformed the medical management of IBD due to their ability to induce a complete control of symptoms, induce mucosal healing in a significant proportion of patients, and reduce the long-term requirements of surgery and hospitalization (6–8).